Nhs_choices Bthft Bradford Teaching HospitalsNHS Foundation Trust NHS Choices
  • Text Size

  • Language

    loading

04 - CNS

NICE Technologies Applicable to this BNF Section
TA Number TA Subject Has the recommendation in the TA been implemented in the organisation for example by changes to the local formulary for drugs, procurement of devices or changes to care pathways? (Yes/No/TA Not Applicable to this organisation)
TA292 Bipolar disorder (adolescents) - aripiprazole (TA292) TA not applicable to this organisation (Any patient who has been commneced on treatment by specialist agencies will continue to receive their treatment if admitted to this organisation)
TA286 Schizophrenia or bipolar disorder - loxapine inhalation (terminated appraisal) (TA286) Yes
TA260 Migraine (chronic) - botulinum toxin type A (TA260) Yes
TA232
Epilepsy (partial) - retigabine (adjuvant) (TA232)

Yes
TA231 Depression - agomelatine (terminated apprasial) (TA231) TA not applicable to this organisation
TA217
Alzheimer's disease - donepezil,galantamine, rivastigmine and memantine (TA217) 
TA not applicable to this organisation (Any patient who has been commenced on treatment by specialist agencies will continue to receive their treatment if admiited to this organisation)
TA213 Schizophrenia - aripiprazole (TA213) TA not applicable to this organisation (Any patient who has been commenced on treatment by specialist agencies will continue to receive their treatment if admitted to this organisation)
TA159 Pain (chronic neuropathic or ischaemic) - spinal cord stimulation (TA159) Yes
TA136 Structural neuroimaging in first episode psychosis (TA136) TA not applicable to this organisation
TA123 Smoking cessation - varenecline (TA123) Yes
TA115
Drug misuse - Natrexone (TA115) TA not applicable to this organisation (any patient who has been commenced on treatment by specialist agencies will continue to receive their treatment if admitted to this organisation)
TA114
Drug misuse - methadone & buprenorphine (TA114)
TA not applicable to this organisation (any patient who has been commenced on treatment by specialist agencies will continue to receive their treatment if admitted to this organisation)
TA102 Conduct disorder in children - parent-training/education programmes (TA102) TA not applicable to this organisation
TA98 Atention deficit hyperactivity disorder (ADHD) - methylphenidate, atomoxitene and dexamfetamine (review) (TA98) TA not applicable to this organisation (any patient who is admitted to this organsiation where they have been commenced on any of these therapies will have their treatment continued)
TA97 Depression and anxiety - computerised cognitive behavioural therapy (CCBT) (TA97) TA not applicable to this organisation
TA77 Insomnia - newer hypnotic drugs (TA77) Yes
TA59 Electroconvulsive therapy (ECT) (TA59) TA not applicable to this organisation
TA20
Motor neurone disease - riluzole (TA20)
Yes